Patrick P. Lally

OrbiMed Advisors LLC is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. It was founded by Sven Borho and Carl Gordon in 1989. The firm provides discretionary investment management services to US and non-US public and private funds.

Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York.

AcuFocus, Inc. develops KAMRA inlay for the treatment of presbyopia. Its KAMRA inlay is an intra-corneal inlay designed to create a small aperture effect, allowing the eye to see near and intermediate objects more clearly. The company was founded in 2001 and is headquartered in Irvine, CA.

Vero Biotech LLC is a biotechnology company, which focuses on the design, development and commercialization of inhaled nitric oxide delivery systems to address the unmet medical needs of patients with cardiopulmonary conditions. It develops a drug, GeNOsyl to meet the needs of patients and care providers. The company was founded by David H. Fine in 2006 and is headquartered in Atlanta, GA.

WaveTec Vision Systems, Inc. develops and provides wavefront measurement technologies. It focuses on research, development, manufacturing, and distribution of the Optiwave Refractive Analysis (ORA) system with VerifEye used during cataract surgery. The firm offers ophthalmic medical devices. The company was founded by Kenneth C. Aldrich, William B. Adams, Thomas J. Berryman, and Tony Van Heugten in 1997 and is headquartered in Aliso Viejo, CA.

eyeonics, Inc. designs, develops, manufactures and sells premium intraocular lenses. Its lenses are implantable devices that replace the natural lens in the human eye, typically after the natural lens has developed cataracts that can significantly impair vision. The firm's products are designed to both replace a cataractous lens and correct a refractive error. The company was founded by Andrew J. Corley and Stuart J. Cumming in 1998 and is headquartered in Aliso Viejo, CA.

Riverside Partners LLC (Riverside Partners) is a private equity firm founded in 1989. The firm is headquartered in Boston, Massachusetts.

Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC.

The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care.

Interward Asset Management, Ltd. (IAML) is a Canadian multi-family office headquartered in Toronto, Ontario. The firm was founded by Kim Ward in 1990. IAML serves a discrete number of high-net-worth clients focused on private and public equities.

Maryland Venture Fund is an evergreen fund seeks investment opportunities in companies located in the United States. The fund focuses on companies operating in the technology sector. It provides financing for seed and early stage capital requirements with an investment size ranging from $500K to $2 million.

Equinox Ophthalmic, Inc. operates as a biotechnology company. It specializes in cataract, corneal and glaucoma surgery. The company was founded by John Berdahl and is headquartered in Sioux Falls, SD.

Spruce Point Capital Management LLC (Spruce Point) is an independent registered investment advisor and hedge fund manager headquartered in Riverhead, New York. The firm was founded by Ben Axler and David Katona in 2009. Spruce Point provides investment portfolio management on a discretionary basis to private pooled investment vehicles, the securities of which are offered to investors on a private placement basis.

OCTANe connects people and ideas with capital and resources for technology growth in Orange County. It stimulates technology job growth and wealth creation; helps entrepreneurs turn ideas into successful businesses; helps companies connect with funding and growth resources; helps senior executives access intelligence, new technologies, and talent; helps develop technology business leaders; and creates a forum for technology company leaders to have an impact on the future. The company offers LaunchPad, a pro-bono accelerator for startup companies in the technology, life science, and clean tech industries. The company was founded in 2002 and is headquartered in Aliso Viejo, CA.

Abundance Ventures LLC (Abundance Ventures) is a venture capital subsidiary of Abundance Partners LLC founded by Vladimir Efros in 2003. The firm is headquartered in New York.

AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA.

Brace Pharmaceuticals, Inc (Brace Pharmaceuticals) is a venture capital firm founded in 2013. The firm is headquartered in Atlanta.

Virta Health Corp. develops and offers software that offers healthcare solutions. It develops and individualizes therapies to restore metabolic health in chronic disease patients. The company was founded by Sami Inkinen, Stephen Phinney and Jeff Volek in 2014 and is headquartered in San Francisco, CA.

LumiraDx UK Ltd. is a POC diagnostic company. The firm focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers at the point of need, thereby enabling more informed medical decisions to improve health outcomes. It develops and launches platform, which is an integrated system comprised of a small, versatile Instrument, precise, low-cost microfluidic test strips, and seamless, secure digital connectivity. The company was founded by Ronald Zwanziger, Jerry McAleer and David Scott on September 5, 2014 and is headquartered in George Town, Cayman Islands.

Revolo Biotherapeutics Ltd. develops immunologic and inflammatory medications. It develops disease resetting therapeutics for immuno-inflammatory diseases. The company was founded in 2011 and is headquartered in Stevenage, the United Kingdom.

Aviana Molecular Technologies LLC develops technologies for point of care diagnostic of infections. It develops a miniaturized biosensor capable of attaching to a smartphone or smart device through Bluetooth or other wireless connections. The company's diagnostic system is a diagnostic platform that can accurately, detect a target infectious disease, biomarkers or proteins in both clinical and scientific research settings. Its platform uses the latest developments in cellular communications, semiconductor electronics, micro-fluidics and manufacturing methods to create a unique point-of-care diagnostic platform to detect biomarkers or infections. The company was founded by Vanaja Ragavan in 2008 and is headquartered in Orlando, FL.

Flying L Management LLC (Flying L Management) is a venture capital firm founded in 2016. The firm is headquartered in Newport beach, California.

IOR Partners LLC develops office-based surgery suites. The company was founded by Rick Prell and is headquartered in Boulder City, NV.

Vialase, Inc. provides healthcare services. The company is headquartered in Aliso Viejo, CA.

OS Therapies, Inc. operates as a clinical stage biopharmaceutical company. It engages in identification, development, and commercialization of treatments for Osteosarcoma and other related diseases. The company was founded by Paul A. Romness on April 12, 2018 and is headquartered in Rockville, MD.

ValenzaBio, Inc. develops safe and effective treatment options for patients with autoimmune and inflammatory diseases. The company is headquartered in Bethesda, MD.

Part of LumiraDX Ltd., LumiraDx UK Ltd. is a healthcare company based in London, UK. LumiraDx was acquired by CA Healthcare Acquisition Corp. on September 28, 2021 for $2,537.21 million. The British company offers innovative diagnostic solutions for community-based healthcare, including point-of-care testing, digital connectivity, and diagnostic-led therapy solutions for chronic conditions. LumiraDx Fast Lab Solutions is a dedicated business unit that supports high-complexity laboratory testing. The company's bespoke, high-throughput manufacturing line produces precise microfluidic test strips for their diagnostic platform, which delivers results comparable to standard laboratory reference methods. The company was founded in 2014 by Ronald Zwanziger and Jerome Francis McAleer, with Zwanziger serving as CEO since then.

Neurolens, Inc. is a company that commercializes breakthrough technology to improve vision care. The company's patented contoured prism technology provides visual comfort for the nearly 65% of US adults who complain of headaches, neck/shoulder pain, and eyestrain when using digital devices, reading, or doing detail work. The company is based in Coppell, TX. Inspired by a breakthrough discovery linking optometry and neurology, Neurolens is unlocking a new dimension of vision care. The Neurolens contoured prism design helps the eyes work together comfortably, bringing the eyes into alignment to relieve painful symptoms. The technology is only available to independent eye care providers. The company was founded in 2012 by Davis Corley, and Pierre Bertrand has been the CEO of the company since 2019.